Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)Safety and Efficacy of Early Treatment With Deferiprone in Infants and Young Children
Phase 4
Completed
- Conditions
- Beta Thalassemia Major AnemiaIron Overload
- Interventions
- Drug: Placebo
- First Posted Date
- 2018-07-19
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Chiesi Canada Corp
- Target Recruit Count
- 64
- Registration Number
- NCT03591575
- Locations
- 🇪🇬
Ain Shams University Children's Hospital, Cairo, Egypt
🇪🇬Pediatric Hospital of Cairo University, Cairo, Egypt
🇪🇬The Clinical Research Center, Faculty of Medicine, Cairo University, Cairo, Egypt
Compassionate Use of Deferiprone in Patients With PKAN
- Conditions
- Pantothenate Kinase-Associated Neurodegeneration
- First Posted Date
- 2015-12-21
- Last Posted Date
- 2022-11-14
- Lead Sponsor
- Chiesi Canada Corp
- Registration Number
- NCT02635841
News
No news found